GLI2 and gastric cancer: In this study, our data clearly demonstrate that the GLI2/DEC1/ZEB1 signaling axis promoted EMT and enhanced CDDP resistance of GC cells, suggesting that inhibition of GLI2 could enhance therapeutic efficacy in patients with GC.